Latest Breaking News On - அடுத்தது ஜெநரேஶந் ஆய்வகங்கள் - Page 1 : comparemela.com

Next Generation Labs Granted Australian Patent for the Use of TFN® Combinational R- and S-Isomer Synthetic Nicotine in Tobacco Cessation Products Share Article The use of combinational and variable isomeric ratios of R and S synthetic nicotine may ultimately assist adults in quitting or reducing their overall dependence on tobacco. TFN .future combinational R- and S-isomer nicotine formulations may prove to be less addictive than natural or biosimilar standalone S-isomer nicotine, and could potentially help achieve the broader public health goal of providing adult consumers with a satisfying, but non-addictive form of nicotine SAN DIEGO (PRWEB) July 22, 2021 Next Generation Labs LLC, the company that was first to manufacture and market bulk high quality synthetic R-S, S- and R-isomer nicotine under the TFN® brand, is pleased to announce that the Company has been granted an Australian patent (IP Australia #201

United statesSouth koreaGeneration labsNext generation labsஒன்றுபட்டது மாநிலங்களில்தெற்கு கொரியாஜெநரேஶந் ஆய்வகங்கள்அடுத்தது ஜெநரேஶந் ஆய்வகங்கள்